Results of a single blind, randomized, placebo-controlled clinical trial to study the effect of intravenous L-carnitine supplementation on health-related quality of life in Indian patients on maintenance hemodialysis

Indian Journal of Medical Sciences

Volumn 60, Issue 4, 2006, Pages 143-153

  Rathod, Rahul ^a   Baig, Mirza Siraz ^a   Khandelwal, P N ^a   Kulkarni, S G ^a   Gade, P R ^a   Siddiqui, Samra ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Hemodialysis; L carnitine; Quality of life

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; CARNITINE; CREATININE; HEMOGLOBIN; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; NIFEDIPINE; PLACEBO; SERUM ALBUMIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INDIA; MAINTENANCE THERAPY; MALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SINGLE BLIND PROCEDURE; SYMPTOMATOLOGY;

EID: 33646450266     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.24678     Document Type: Article

References (17)

1. Goral S. Levocarnitine's role in the treatment of patients with end-stage renal disease: A review. Dial Transplant 2001;30:530-8.
2. Schreiber BD. Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients. Blood Purif 2006;24:128-39.
3. Schreiber B, Lewis V. Management of carnitine deficiency in ESRD patients undergoing dialysis: Challenges and considerations. Dial Transplant 2001;30:207-12.
4. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. Association among SF36 quality of life measures and nutrition, hospitalization and mortality in hemodialysis. J Am Soc Nephrol 2001;12:2797-806.
5. Sakurauchi Y, Matsumoto Y, Shinzato T, Takai I, Nakamura Y, Sato M, et al. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients. Am J Kidney Dis 1998;32:258-64.
6. Matsumoto Y, Amano I, Hirose S, Tsuryta Y, Hara S, Murata M, et al. Effects of L-carnitine supplementation on renal anemia in poor responders to erythropoietin. Blood Purif 2000;19:24-32.
7. Brass EP, Adler S, Sietsema KE, HiattWR, Orlando AM, Amato A. Intravenous L-carnitine increases plasma carnitine, reduces fatigue and may preserve exercise capacity in hemodialysis patients. Am J Kidney Dis 2001;37:1018-28.
8. Modified SF36 Questionnaire and MS Excel programme sheet. Available at www.nephrology.rei.edu/qol.htm.
9. Abramson JH. WINPEPI (PEPI-for-Windows) computer programs for epidemiologists. Epidemiologic Perspectives & Innovations: 2004. p. 6.
10. Hurot J, Cucherat M, Haugh M, Fouque D. Effects of L-Carnitine Supplementation in Maintenance Hemodialysis Patients: A Systematic Review. J Am Soc Nephrol 2002;13:708-14.
11. Arduini A, Mancinelli G, Ramsay R. Palmitoyl-L-carnitine, a metabolic intermediate of the fatty acid incorporation pathway in erythrocyte membrane phospholipids. Biochem Biophys Res Commun 1990;173:212-7.
12. Arduini A, Mancinelli G, Radatti G, Dottori S, Molajoni F, Ramsay R. Role of carnitine and carnitine palmitoyltransferase as integral components of the pathway for membrane phospholipid fatty acid turnover in intact human erythrocytes. J Biol Chem 1992;267:12673-81.
13. Labonia WD, Morelli OH Jr, Gimenez MI. Effects of L-carnitine on sodium transport in erythrocytes from dialyzed uremic patients. Kidney Int 1987;32:754-9.
14. Labonia WD. L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. Am J Kidney Dis 1995;26:757-64.
15. Sloan RS, Kastan B, Rice SI, Sallee CW, Yuenger NJ, Smith B, et al. Quality of life during and between hemodialysis treatments: roel of L-carnitine supplementation. Am J Kidney Dis 1998;32:265-72.
16. Eknoyan G, Latos DL, Lindberg J. Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder National Kidney Foundation carnitine consensus conference. Am J Kidney Dis 2003;41:868-76.
17. Steiber AL, Davis AT, Spry L, Strong J, Buss ML, Ratkiewicz MM, et al. Carnitine treatment improved quality-of-life measure in a sample of Midwestern hemodialysis patients. J Parenter Enteral Nutr 2006;30:10-5.